Trials / Recruiting
RecruitingNCT06971796
EURO-STIM Registry
Longitudinal Outcomes and Adherence of the Inspire System, EURO-STIM Registry
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,000 (estimated)
- Sponsor
- Inspire Medical Systems, Inc. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The registry is to measure longitudinal outcomes and adherence of the Inspire System. The goal of the registry is to capture the life cycle of the patient's use of the Inspire System through routine clinical care visits. There are no required interventions or testing.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Inspire UAS System | Participants will be implanted with the Inspire UAS System, which is a permanent, implantable therapy that consists of three implantable components: an IPG, a stimulation lead, and a sensing lead. In addition, the study subject receives a remote control to activate the therapy. |
Timeline
- Start date
- 2025-05-26
- Primary completion
- 2035-04-01
- Completion
- 2035-04-01
- First posted
- 2025-05-14
- Last updated
- 2025-09-08
Locations
21 sites across 7 countries: Austria, Belgium, France, Germany, Netherlands, Switzerland, United Kingdom
Source: ClinicalTrials.gov record NCT06971796. Inclusion in this directory is not an endorsement.